BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32641951)

  • 1. Trehalose Neuroprotective Effects on the Substantia Nigra Dopaminergic Cells by Activating Autophagy and Non-canonical Nrf2 Pathways.
    Darabi S; Noori-Zadeh A; Abbaszadeh HA; Rajaei F; Bakhtiyari S
    Iran J Pharm Res; 2019; 18(3):1419-1428. PubMed ID: 32641951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMER28 Attenuates Dopaminergic Toxicity Mediated by 6-Hydroxydopamine in the Rats via Modulating Oxidative Burdens and Autophagy-Related Parameters.
    Darabi S; Noori-Zadeh A; Rajaei F; Abbaszadeh HA; Bakhtiyari S; Roozbahany NA
    Neurochem Res; 2018 Dec; 43(12):2313-2323. PubMed ID: 30288644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Puerarin attenuates neuronal degeneration in the substantia nigra of 6-OHDA-lesioned rats through regulating BDNF expression and activating the Nrf2/ARE signaling pathway.
    Li R; Liang T; Xu L; Zheng N; Zhang K; Duan X
    Brain Res; 2013 Jul; 1523():1-9. PubMed ID: 23747813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rb1 protects dopaminergic neurons from inflammatory injury induced by intranigral lipopolysaccharide injection.
    Li DW; Zhou FZ; Sun XC; Li SC; Yang JB; Sun HH; Wang AH
    Neural Regen Res; 2019 Oct; 14(10):1814-1822. PubMed ID: 31169200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of swimming training in a mouse model of Parkinson's disease induced by 6-hydroxydopamine.
    Goes AT; Souza LC; Filho CB; Del Fabbro L; De Gomes MG; Boeira SP; Jesse CR
    Neuroscience; 2014 Jan; 256():61-71. PubMed ID: 24090962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin Modulates p62-Keap1-Nrf2-Mediated Autophagy in Rotenone-Induced Parkinson's Disease Mouse Models.
    Rathore AS; Singh SS; Birla H; Zahra W; Keshri PK; Dilnashin H; Singh R; Singh S; Singh SP
    ACS Chem Neurosci; 2023 Mar; ():. PubMed ID: 36989171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ukgansan protects dopaminergic neurons from 6-hydroxydopamine neurotoxicity via activation of the nuclear factor (erythroid-derived 2)-like 2 factor signaling pathway.
    Eo H; Huh E; Sim Y; Oh MS
    Neurochem Int; 2019 Jan; 122():208-215. PubMed ID: 30508559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17 β-Estradiol Oxidative Stress Attenuation and Autophagy-Induced Dopaminergic Neuroprotection.
    Varmazyar R; Noori-Zadeh A; Rajaei F; Darabi S; Bakhtiyari S
    Cell J; 2019 Apr; 21(1):1-6. PubMed ID: 30507082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
    Liu H; Jia L; Chen X; Shi L; Xie J
    Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
    Zheng L; Wang H; Ba YY; Liu HL; Wang M; Guo WW; Wu X; Yang H
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1660-5. PubMed ID: 25095380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
    Pang Y; Lin S; Wright C; Shen J; Carter K; Bhatt A; Fan LW
    Neuroscience; 2016 Mar; 318():157-65. PubMed ID: 26777890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease.
    Lapchak PA; Araujo DM; Hilt DC; Sheng J; Jiao S
    Brain Res; 1997 Nov; 777(1-2):153-60. PubMed ID: 9449424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
    Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F
    J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy-related protein expression in the substantia nigra and eldepryl intervention in rat models of Parkinson's disease.
    Liu B; Sun J; Zhang J; Mao W; Ma Y; Li S; Cheng X; Lv C
    Brain Res; 2015 Nov; 1625():180-8. PubMed ID: 26342896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
    Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
    Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotenone impairs autophagic flux and lysosomal functions in Parkinson's disease.
    Wu F; Xu HD; Guan JJ; Hou YS; Gu JH; Zhen XC; Qin ZH
    Neuroscience; 2015 Jan; 284():900-911. PubMed ID: 25446361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p62/SQSTM1 protects against cisplatin-induced oxidative stress in kidneys by mediating the cross talk between autophagy and the Keap1-Nrf2 signalling pathway.
    Liao W; Wang Z; Fu Z; Ma H; Jiang M; Xu A; Zhang W
    Free Radic Res; 2019 Jul; 53(7):800-814. PubMed ID: 31223046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease.
    He Q; Koprich JB; Wang Y; Yu WB; Xiao BG; Brotchie JM; Wang J
    Mol Neurobiol; 2016 May; 53(4):2258-68. PubMed ID: 25972237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
    J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
    Khan MM; Ahmad A; Ishrat T; Khan MB; Hoda MN; Khuwaja G; Raza SS; Khan A; Javed H; Vaibhav K; Islam F
    Brain Res; 2010 Apr; 1328():139-51. PubMed ID: 20167206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.